0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Surgical Technique | Surgeon's Corner

Treatment of Proliferative Diabetic Retinopathy Using Viscosurgery With Vital Dye FREE

Jeroni Nadal, MD; María José Capella, MD
[+] Author Affiliations

Author Affiliations: Centro de Oftalmología Barraquer, Barcelona, Spain.


Arch Ophthalmol. 2011;129(10):1358-1360. doi:10.1001/archophthalmol.2011.285.
Text Size: A A A
Published online

Viscosurgery is a surgical procedure based on the injection of viscoelastic material between the retinal surface and the fibrovascular tissue in proliferative diabetic retinopathy (PDR), with the aim of separating these structures to facilitate their dissection. We describe a modified viscosurgical technique in which the viscoelastic material is combined with a vital dye (trypan blue), which allows us to determine the degree of adhesion between the structures. Viscosurgery with vital dye has advantages compared with conventional viscosurgery and constitutes a useful surgical approach in complicated cases of severe PDR, enhancing efficiency and safety in the dissection of fibrovascular proliferations and minimizing iatrogenic damage to the underlying retina. We used trypan blue viscosurgery in 8 eyes of 8 patients with severe PDR; in all cases, a satisfactory outcome was obtained without evidence of any complications.

Figures in this Article

Advances in surgical treatment of complications in proliferative diabetic retinopathy (PDR) have led to improved anatomic and functional results. Correct dissection of the vitreous cortex and the preretinal fibrovascular tissue is essential to reduce the incidence of postoperative rebleeding and the recurrence of retinal detachment. The conventional dissection technique, using instruments such as surgical forceps and scissors, produces favorable results in most cases, but when fibrovascular membranes strongly adhere to the retinal surface, technical difficulties can occur. Viscosurgery is a surgical procedure based on injecting viscoelastic material between the retinal surface and the fibrovascular tissue in PDR, with the aim of separating these structures to facilitate the dissection of the membranes. Herein, we describe the surgical technique of viscosurgery with vital dye used by our team to treat complicated cases of severe PDR. The technique allows favorable visualization of the fibrovascular membranes and, thus, facilitates their safe dissection.

One milliliter of 1% sodium hyaluronate is mixed with 0.1 mL of trypan blue dye in a 2-mL syringe until a homogenous mixture containing no air bubbles is obtained. This result is achieved by a simple technique of stirring with circular motions using a 30-gauge needle in a horizontal position within the syringe. Then, the stained viscoelastic material is returned to the original injector, which is connected to a 30-gauge curved cannula with a bayonet fitting to prevent accidental ejection when pressing the plunger.

After standard vitrectomy with a 23-gauge 3-port system, we remove the microcannula and introduce the 30-gauge curved cannula through the sclerotomic opening. The stained viscoelastic solution is injected between the posterior hyaloid–fibrovascular proliferation complex and the retinal surface to separate these structures. Viscoelastic staining with try pan blue allows us to obtain a retinal elevation map and to visualize the degree of adhesion between the structures. The darkest areas correspond to regions with less adhesion because the dye tends to accumulate in larger spaces between the structures; the lighter areas with less dye correspond to areas with greater adherence and less separation (Figure 1).

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Single-frame photograph taken from the ocular surgery video after injection of stained viscoelastic material between the retina and fibrovascular proliferations. The darker shades indicate greater separation between the structures and the lighter shades reflect a stronger bond between them.

After the dissection, vitrectomy is completed, the viscoelevated fibrovascular membranes are dissected with the victrectomy probe or with forceps and scissors if necessary, and all traces of viscoelastic material are removed by aspiration. Finally, the remaining procedures are completed in each case for posterior segment stabilization (subretinal fluid drainage, exchange of fluid to gas or silicone oil, and photocoagulation). A video of the surgical procedure is available.

The use of viscoelastic materials in vitreoretinal surgery was first described by Stenkula and Törnquist1 in 1983. The authors demonstrated the usefulness of sodium hyaluronate to facilitate the dissection of epiretinal fibrovascular and fibroglial membranes in severe PDR, elevating and separating them from the surface of the retina. Years later, Stenkula et al2 used yellow-stained sodium hyaluronate with sodium fluorescein to enhance visualization and injection under the membranes and to simplify the removal of the substance at the end of surgery. They also reported the possibility of using a type of sodium hyaluronate that is 10-fold more viscous (Healon-GV; Abbott Medical Optics, Inc, Abbott Park, Illinois), which facilitated safer dissection in cases of membranes firmly attached to the retina.3 In 1988, McLeod and James4 also showed the usefulness of retinal viscodelamination with methylcellulose or 1% sodium hyaluronate to separate the vitreous cortex and the epiretinal fibrovascular membranes in 40 eyes with severe PDR. The authors stated that this technique was especially useful in cases of poorly vascularized membranes with combined tractional and rhegmatogenous retinal detachment but that it entailed a significant risk of iatrogenic retinal breaks and increased bleeding in cases of highly vascularized and adherent membranes. Also, they reported postoperative recurrences of epiretinal proliferation, which they attributed to residual viscoelastic material that proved difficult to remove entirely, with preretinal retention of growth factors. For these reasons, the authors indicated that the technique had been abandoned in favor of purely mechanical methods that minimized the risk of proliferation.

More recently, Grigorian et al5,6 compared the conventional technique of dissection using forceps and scissors with viscodissection and concluded that the latter was a safe and equally effective alternative for surgical management of PDR. In contrast to the experience of McLeod and James,4 these authors did not observe an increase in intraoperative bleeding or difficulty in the removal of viscoelastic material. In their view, the viscoelastic material helps maintain transparency during surgery by limiting diffusion of blood into the vitreous cavity.

We present a modified technique of viscosurgery in which viscoelastic material is combined with a vital dye (trypan blue) in complicated cases of severe PDR. Viscoelastic material is most useful for separating the posterior hyaloid–fibrovascular membrane complex from the retinal surface. At the same time, the vital dye allows for a topographic elevation map of these membranes owing to the variable color intensity of the underlying viscoelastic material, as mentioned in the “Surgical Technique” section of the text. The darker the shade, the greater the separation; this allows fast and safe dissection of the proliferations. In contrast, the lighter shades reflect a much smaller space between the retinal surface and the membranes, implying greater adhesion between them, so the dissection procedure must be performed with extreme care to avoid iatrogenic damage to the retina (Figure 2). Also, the clearly visible color of the viscoelastic material facilitates its complete removal, minimizing the risk of residue at the end of surgery, as established by Stenkula et al.2 In the technique we describe, the viscoelastic material is not actually used for dissecting the fibrovascular proliferations, as in conventional viscosurgery, but for defining their epicenters and the correct plane for fast and safe dissection. This, along with the enhanced visual advantage provided by its combination with the vital dye, makes it a useful procedure in complicated cases of PDR.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Single-frame photograph taken from another ocular surgery video. The stained viscoelastic material at the top of the picture is lighter than that below. This indicates greater adhesion between the retina and fibroglial proliferations, requiring extra care for their dissection.

Regarding the potential toxic effects of trypan blue in vitreoretinal surgery, 2 consecutive clinical studies7,8 have shown no signs of retinal toxic effects or alteration of the retinal pigment epithelium associated with the dye. Experimental studies using animal models show more conflicting results, which may be due partly to methodological differences. Lüke at al9 observed irreversible retinal damage due to 0.15% trypan blue. Veckeneer et al10 reported signs of retinal toxic effects after prolonged exposure to 0.2% trypan blue, although a concentration of 0.06% proved to be safe. In contrast, Jackson et al11 demonstrated the safety of the dye with concentrations as high as 0.2% in retinal pigment epithelium cell culture and glial cells. In our surgical experience, we have observed no alterations or signs suggestive of toxic effects of the dye.

We used trypan blue viscosurgery in 8 eyes of 8 patients with severe PDR and fibrovascular proliferations that firmly adhered to the retina; in all cases, a satisfactory outcome was obtained without evidence of iatrogenic retinal breaks, leakage of viscoelastic material into the subretinal space, or any other complications. We have extensive experience in conventional viscosurgery and have observed a stronger definition of the epicenters and of the correct plane for dissection with trypan blue viscosurgery. This technique can improve the ability of surgeons to visualize surgical planes and may enhance efficiency and safety.

Viscosurgery with vital dye offers advantages compared with traditional viscosurgery because the intensity of the dye color provides an indication of the degree of fibrovascular membrane adherence to the retinal surface. Therefore, we believe this technique constitutes a safe and useful surgical approach in complicated cases of severe PDR, allowing for precise and rapid membrane dissection and minimizing the risk of iatrogenic damage to the underlying retina.

Correspondence: María José Capella, MD, Centro de Oftalmología Barraquer, Calle Muntaner 314, 08021 Barcelona, Spain (mjcapella@barraquer.com).

Submitted for Publication: June 16, 2010; final revision received September 30, 2010; accepted October 4, 2010.

Financial Disclosure: None reported.

Stenkula S, Törnquist R. Use of Healon in vitrectomy and difficult retinal detachment. In: Miller D, Stegmann R, eds. Healon (Sodium Hyaluronate): A Guide to Its Use in Ophthalmic Surgery. New York, NY: John Wiley & Sons; 1983:207-221
Stenkula S, Ivert L, Berglin L, Crafoord S. Healon Yellow as a surgical tool in maneuvering intraocular tissues.  Ophthalmic Surg. 1992;23(10):708-710
PubMed
Crafoord S, Stenkula S. Healon GV in posterior segment surgery.  Acta Ophthalmol (Copenh). 1993;71(4):560-561
PubMed   |  Link to Article
McLeod D, James CR. Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease.  Br J Ophthalmol. 1988;72(6):413-419
PubMed   |  Link to Article
Grigorian RA, Castellarin A, Fegan R,  et al.  Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling.  Br J Ophthalmol. 2003;87(6):737-741
PubMed   |  Link to Article
Grigorian RA, Castellarin A, Bhagat N, Del Priore L, Von Hagen S, Zarbin MA. Use of viscodissection and silicone oil in vitrectomy for severe diabetic retinopathy.  Semin Ophthalmol. 2003;18(3):121-126
PubMed   |  Link to Article
Vote BJ, Russell MK, Joondeph BC. Trypan blue-assisted vitrectomy.  Retina. 2004;24(5):736-738
PubMed   |  Link to Article
Teba FA, Mohr A, Eckardt C,  et al.  Trypan blue staining in vitreoretinal surgery.  Ophthalmology. 2003;110(12):2409-2412
PubMed   |  Link to Article
Lüke C, Lüke M, Dietlein TS,  et al.  Retinal tolerance to dyes.  Br J Ophthalmol. 2005;89(9):1188-1191
PubMed   |  Link to Article
Veckeneer M, van Overdam K, Monzer J,  et al.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.  Graefes Arch Clin Exp Ophthalmol. 2001;239(9):698-704
PubMed   |  Link to Article
Jackson TL, Hillenkamp J, Knight BC,  et al.  Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures.  Invest Ophthalmol Vis Sci. 2004;45(8):2778-2785
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Single-frame photograph taken from the ocular surgery video after injection of stained viscoelastic material between the retina and fibrovascular proliferations. The darker shades indicate greater separation between the structures and the lighter shades reflect a stronger bond between them.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Single-frame photograph taken from another ocular surgery video. The stained viscoelastic material at the top of the picture is lighter than that below. This indicates greater adhesion between the retina and fibroglial proliferations, requiring extra care for their dissection.

Tables

References

Stenkula S, Törnquist R. Use of Healon in vitrectomy and difficult retinal detachment. In: Miller D, Stegmann R, eds. Healon (Sodium Hyaluronate): A Guide to Its Use in Ophthalmic Surgery. New York, NY: John Wiley & Sons; 1983:207-221
Stenkula S, Ivert L, Berglin L, Crafoord S. Healon Yellow as a surgical tool in maneuvering intraocular tissues.  Ophthalmic Surg. 1992;23(10):708-710
PubMed
Crafoord S, Stenkula S. Healon GV in posterior segment surgery.  Acta Ophthalmol (Copenh). 1993;71(4):560-561
PubMed   |  Link to Article
McLeod D, James CR. Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease.  Br J Ophthalmol. 1988;72(6):413-419
PubMed   |  Link to Article
Grigorian RA, Castellarin A, Fegan R,  et al.  Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling.  Br J Ophthalmol. 2003;87(6):737-741
PubMed   |  Link to Article
Grigorian RA, Castellarin A, Bhagat N, Del Priore L, Von Hagen S, Zarbin MA. Use of viscodissection and silicone oil in vitrectomy for severe diabetic retinopathy.  Semin Ophthalmol. 2003;18(3):121-126
PubMed   |  Link to Article
Vote BJ, Russell MK, Joondeph BC. Trypan blue-assisted vitrectomy.  Retina. 2004;24(5):736-738
PubMed   |  Link to Article
Teba FA, Mohr A, Eckardt C,  et al.  Trypan blue staining in vitreoretinal surgery.  Ophthalmology. 2003;110(12):2409-2412
PubMed   |  Link to Article
Lüke C, Lüke M, Dietlein TS,  et al.  Retinal tolerance to dyes.  Br J Ophthalmol. 2005;89(9):1188-1191
PubMed   |  Link to Article
Veckeneer M, van Overdam K, Monzer J,  et al.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.  Graefes Arch Clin Exp Ophthalmol. 2001;239(9):698-704
PubMed   |  Link to Article
Jackson TL, Hillenkamp J, Knight BC,  et al.  Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures.  Invest Ophthalmol Vis Sci. 2004;45(8):2778-2785
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.